Analysis of survival with modified docetaxel, cisplatin, fluorouracil (mDCF), and bevacizumab (BEV) in patients with metastatic gastroesophageal (GE) adenocarcinoma: Results of a phase II clinical trial

被引：0
|
作者：
Kelsen, D. [1 ]
Jhawer, M. [1 ]
Ilson, D. [1 ]
Tse, A. [1 ]
Randazzo, J. [1 ]
Robinson, E. [1 ]
Capanu, M. [1 ]
Shah, M. A. [1 ]
机构：
[1] MSKCC, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4512
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Phase II trial of preoperative bevacizumab (Bev), irinotecan (I), cisplatin (C), and radiation (RT) in esophageal adenocarcinoma: Preliminary safety analysis
    Ilson, D.
    Bains, M.
    Rizk, N.
    Rusch, V.
    Flores, R.
    Park, B.
    Shah, M.
    Kelsen, D.
    Miron, B.
    Goodman, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] First-line panitumumab plus docetaxel and cisplatin in advanced gastric or gastroesophageal junction adenocarcinoma: Results of a phase II trial (SPIGA).
    Aldana, Guillermo Alfonso Quintero
    Folgar, Sonia Candamio
    Mendez, Jose Carlos Mendez
    Reboredo, Margarita
    Fernandez, Monica Jorge
    Constenla, Manuel
    Reinoso, Carlos Romero
    Fernandez, Mercedes Salgado
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients
    Ramaswamy, Bhuvaneswari
    Elias, Anthony D.
    Kelbick, Nicole T.
    Dodley, Angela
    Morrow, Mark
    Hauger, Marsha
    Allen, Joan
    Rhoades, Chris
    Kendra, Kari
    Chen, Helen X.
    Eckhardt, S. Gail
    Shapiro, Charles L.
    CLINICAL CANCER RESEARCH, 2006, 12 (10) : 3124 - 3129
  • [24] Phase II trial of bevacizumab, gemcitabine, oxaliplatin in patients with metastatic pancreatic adenocarcinoma
    Kim, G. P.
    Oberg, A. L.
    Foster, N. R.
    Jaslowski, A.
    Flynn, P. J.
    Campbell, D.
    Hedrick, E.
    Gray, L.
    Grothey, A.
    Alberts, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer
    Enzinger, P. C.
    Ryan, D. P.
    Clark, J. W.
    Muzikansky, A.
    Earle, C. C.
    Kulke, M. H.
    Meyerhardt, J. A.
    Blaszkowsky, L. S.
    Zhu, A. X.
    Fidias, P.
    Vincitore, M. M.
    Mayer, R. J.
    Fuchs, C. S.
    ANNALS OF ONCOLOGY, 2009, 20 (03) : 475 - 480
  • [26] Phase II trial of induction and adjuvant bevacizumab with cisplatin and docetaxel in patients with locally advanced NSCLC
    Kris, Mark G.
    Price, Katharine A.
    Rusch, Valerie W.
    Zhao, Binsheng
    Schwartz, Lawrence H.
    Guo, Pingzhen
    Tan, Yangqiang
    Subzwari, Sara
    Finley, David
    Rizvi, Naiyer A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S372 - S372
  • [27] Docetaxel, cisplatin, and fluorouracil;: Docetaxel and cisplatin;: and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma:: A randomized phase II trial of the Swiss Group for Clinical Cancer Research
    Roth, Arnaud D.
    Fazio, Nicola
    Stupp, Roger
    Falk, Stephen
    Bernhard, Juerg
    Saletti, Piercarlo
    Koeberle, Dieter
    Borner, Markus M.
    Rufibach, Kaspar
    Maibach, Rudolf
    Wernli, Martin
    Leslie, Martin
    Glynne-Jones, Robert
    Widmer, Lukas
    Seymour, Matthew
    de Braud, Filippo
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) : 3217 - 3223
  • [28] Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinorna
    Shah, Manish A.
    Ramanathan, Ramesh K.
    Ilson, David H.
    Levnor, Alissa
    D'Adamo, David
    O'Reilly, Eileen
    Tse, Archie
    Trocola, Robin
    Schwartz, Lawrence
    Capanu, Marinela
    Schwartz, Gary K.
    Kelsen, David P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (33) : 5201 - 5206
  • [29] Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction
    Richards, D.
    McCollum, D.
    Wilfong, L.
    Sborov, M.
    Boehm, K. A.
    Zhan, F.
    Asmar, L.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 104 - 108
  • [30] Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: The V-325 study group
    Ajani, Jaffer A.
    Moiseyenko, Vladimir M.
    Tjulandin, Sergei
    Majlis, Alejandro
    Constenla, Manuel
    Boni, Corrado
    Rodrigues, Adriano
    Fodor, Miguel
    Chao, Yee
    Voznyi, Edouard
    Awad, Lucile
    Van Cutsem, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) : 3210 - 3216
12345